Literature DB >> 6901734

Immunoassay of serum conjugates of cholic acid in cystic fibrosis.

G P Davidson, M Corey, F Morad-Hassel, J M Sondheimer, D Crozier, G G Forstner.   

Abstract

Pre- and post-prandial serum conjugates of cholic acid (SCCA) were measured by radioimmunoassay (RIA) in 83 patients with cystic fibrosis (CF), 14 of whom did not have steatorrhoea, and in 25 controls. Of the CF patients with steatorrhoea, 38% had fasting SCCA levels greater than 3 standard deviations above mean fasting control values, whereas no CF patient without steatorrhoea had elevated fasting SCCA levels. Steatorrhoeic patients with palpable livers had higher pre- and post-prandial SCCA levels. Post-prandial SCCA levels failed to discriminate between control and CF groups however. Other serum tests of liver function, including the aspartate amino transferase, alkaline phosphatase, albumin, gamma globulin, and albumin : globulin ratio, failed to correlate with the SCCA. Changes in serum protein constituents correlated strongly with pulmonary dysfunction. The results suggest that elevation of fasting SCCA levels in CF patients is a more sensitive indicator of liver dysfunction than other tests and is a better discriminator than post-prandial SCCA levels between normal and abnormal liver function. The test is recommended for early detection of liver dysfunction in CF patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6901734      PMCID: PMC1146086          DOI: 10.1136/jcp.33.4.390

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Diagnositic value of serum bile acid estimations in liver disease.

Authors:  S Barnes; G A Gallo; D B Trash; J S Morris
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

2.  Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis.

Authors:  E H Oppenheimer; J R Esterly
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

3.  Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man.

Authors:  A E Cowen; M G Korman; A F Hofmann; P J Thomas
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

4.  The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis.

Authors:  J Kattwinkel; L M Taussig; B E Statland; J I Verter
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

5.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

6.  Postprandial serum bile acid for the detection of hepatobiliary disease.

Authors:  N Kaplowitz; E Kok; N B Javitt
Journal:  JAMA       Date:  1973-07-16       Impact factor: 56.272

7.  Radioimmunoassay of conjugated cholyl bile acids in serum.

Authors:  W J Simmonds; M G Korman; V L Go; A F Hofmann
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

8.  The response to infusion of a combination of secretin and pancreozymin in health and disease.

Authors:  K G Wormsley
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

9.  Development of an intravenous bile acid tolerance test. Plasma disappearance of cholylglycine in health.

Authors:  M G Korman; N F LaRusso; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

10.  Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption.

Authors:  N F LaRusso; M G Korman; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

View more
  1 in total

1.  Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.

Authors:  T A Robb; G P Davidson; C Kirubakaran
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.